SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Warns Shire Pharmaceuticals (JOBS), Eisai Company, Ltd. (JOBS) on Promotions

November 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators have warned Shire PLC (SHP.L) and Eisai Co Ltd (4523.T) about drug promotions that minimized the medicines' risks and overstated benefits, letters released on Friday said.
Clinical research Postmarket research Legal Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
 · 
3 min read
 · 
Tristan Manalac
businessman Climbing mountain. Symbol of success, career, leadership and goal
Immuno-oncology
Four Therapies Hanging On in Troubled TIGIT Space
July 7, 2025
 · 
9 min read
 · 
Tristan Manalac
Social media illustration, business concept, web design
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
 · 
3 min read
 · 
Annalee Armstrong
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Immunology and inflammation
Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac